1. Home
  2. CHH vs BIO Comparison

CHH vs BIO Comparison

Compare CHH & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHH
  • BIO
  • Stock Information
  • Founded
  • CHH 1939
  • BIO 1952
  • Country
  • CHH United States
  • BIO United States
  • Employees
  • CHH N/A
  • BIO N/A
  • Industry
  • CHH Hotels/Resorts
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CHH Consumer Discretionary
  • BIO Industrials
  • Exchange
  • CHH Nasdaq
  • BIO Nasdaq
  • Market Cap
  • CHH 5.8B
  • BIO 6.0B
  • IPO Year
  • CHH 1997
  • BIO N/A
  • Fundamental
  • Price
  • CHH $122.88
  • BIO $232.99
  • Analyst Decision
  • CHH Hold
  • BIO Strong Buy
  • Analyst Count
  • CHH 14
  • BIO 4
  • Target Price
  • CHH $133.64
  • BIO $324.25
  • AVG Volume (30 Days)
  • CHH 402.3K
  • BIO 405.4K
  • Earning Date
  • CHH 08-07-2025
  • BIO 07-31-2025
  • Dividend Yield
  • CHH 0.94%
  • BIO N/A
  • EPS Growth
  • CHH 40.19
  • BIO N/A
  • EPS
  • CHH 6.57
  • BIO N/A
  • Revenue
  • CHH $797,663,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • CHH $103.49
  • BIO N/A
  • Revenue Next Year
  • CHH $3.35
  • BIO $3.49
  • P/E Ratio
  • CHH $18.54
  • BIO N/A
  • Revenue Growth
  • CHH N/A
  • BIO N/A
  • 52 Week Low
  • CHH $116.13
  • BIO $211.43
  • 52 Week High
  • CHH $157.86
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • CHH 41.14
  • BIO 51.88
  • Support Level
  • CHH $121.42
  • BIO $222.80
  • Resistance Level
  • CHH $131.40
  • BIO $234.31
  • Average True Range (ATR)
  • CHH 2.82
  • BIO 7.04
  • MACD
  • CHH -0.57
  • BIO 1.55
  • Stochastic Oscillator
  • CHH 15.14
  • BIO 88.43

About CHH Choice Hotels International Inc.

As of Dec. 31, 2024, Choice Hotels operated 654,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (26% of the company's total domestic rooms), while Ascend and Cambria (10% of total domestic rooms) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represent 78% of total rooms in 2024.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: